For many years the synthesis of isoquinoline derivatives has been carried out in our Organic Chemistry Research Laboratory. In the process of pharmacological screening tests, 1-(3, 4-dihydroxybenzyl)-6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline was found to have significant bronchodilating as well as hypotensive actions, as briefly communicated in the previous report (1). This compound ha d been synthesized by Pyman in 1909 (2) and its hypotensive action was reported by Laidlaw in the following year (3). While our work was in progress, Holtz and his co-workers (4) demonstrated the formaton of this compound as a condensation product of dopamine and its enzymatically deaminated product, 3, 4-dihydroxyphenyl-acetaldehyde. They also reported its hypotensive and bronchodilating activities, which were interpreted as a β-sympathomimetic action of this compound. In reference to these studies 1-aralkyl derivatives of tetrahydroisoquinoline (THI) were synthesized and tested their bronchodilating activities. Among the compounds tested, 1-(3, 4, 5-trimthoxybenzyl)-6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline (IX) was observed to be the most active bronchodilator hitherto described in the literature. The relationship between the chemical structure and the bronchodilating activity was investigated in this paper.
Read full abstract